Ouyang P, Qi J, Tong B, Li Y, Cao J, Wang L
Invest Ophthalmol Vis Sci. 2025; 66(3):5.
PMID: 40035727
PMC: 11892527.
DOI: 10.1167/iovs.66.3.5.
Faggiano A, Russo F, Zamponi V, Sesti F, Puliani G, Modica R
J Neuroendocrinol. 2024; 37(2):e13485.
PMID: 39726194
PMC: 11791004.
DOI: 10.1111/jne.13485.
Ray A, Moore T, Naik D, Borsch D
Medicina (Kaunas). 2024; 60(9).
PMID: 39336556
PMC: 11434611.
DOI: 10.3390/medicina60091515.
Tran M
Front Genet. 2024; 15:1376123.
PMID: 39233736
PMC: 11371700.
DOI: 10.3389/fgene.2024.1376123.
Zhang C, Jiang S, Cao J, Xu Y, Wang X, Li R
Front Microbiol. 2024; 15:1420167.
PMID: 39193433
PMC: 11347282.
DOI: 10.3389/fmicb.2024.1420167.
Causal effect of gut microbiota of on the clinical pathway of "Influenza-Subacute Thyroiditis-Hypothyroidism".
Zhang X, Li P, Wang D, Li H, Kong X, Zhang G
Front Microbiol. 2024; 15:1354989.
PMID: 38476943
PMC: 10929266.
DOI: 10.3389/fmicb.2024.1354989.
Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?.
Uccella S
Endocr Pathol. 2024; 35(2):91-106.
PMID: 38470548
PMC: 11176254.
DOI: 10.1007/s12022-024-09807-2.
Investigating causal associations among gut microbiota, metabolites and autoimmune hypothyroidism: a univariable and multivariable Mendelian randomization study.
Liu X, Yuan J, Liu S, Tang M, Meng X, Wang X
Front Immunol. 2024; 14:1213159.
PMID: 38239342
PMC: 10794377.
DOI: 10.3389/fimmu.2023.1213159.
Causal analysis of the gut microbiota in differentiated thyroid carcinoma: a two-sample Mendelian randomization study.
Quan Z, Zhang X, Wang S, Meng Y
Front Genet. 2023; 14:1299930.
PMID: 38155712
PMC: 10753834.
DOI: 10.3389/fgene.2023.1299930.
PitNETs and the gut microbiota: potential connections, future directions.
Nie D, Li C, Zhang Y
Front Endocrinol (Lausanne). 2023; 14:1255911.
PMID: 38027221
PMC: 10657991.
DOI: 10.3389/fendo.2023.1255911.
Pancreatic neuroendocrine tumor progression and resistance to everolimus: the crucial role of NF-kB and STAT3 interplay.
Vitali E, Valente G, Panzardi A, Laffi A, Zerbi A, Uccella S
J Endocrinol Invest. 2023; 47(5):1101-1117.
PMID: 37882947
DOI: 10.1007/s40618-023-02221-1.
Exploring the Relationship between Obesity, Metabolic Syndrome and Neuroendocrine Neoplasms.
Lan X, Fazio N, Abdel-Rahman O
Metabolites. 2022; 12(11).
PMID: 36422290
PMC: 9693308.
DOI: 10.3390/metabo12111150.
The relationships between the gut microbiota and its metabolites with thyroid diseases.
Jiang W, Lu G, Gao D, Lv Z, Li D
Front Endocrinol (Lausanne). 2022; 13:943408.
PMID: 36060978
PMC: 9433865.
DOI: 10.3389/fendo.2022.943408.
Changes of Intestinal Flora and Its Relationship with Nutritional Status for Patients with Cancer Pain.
Zhang P, Zhu N, Wang P, Zhuang F, Ding D, Zhou D
Comput Math Methods Med. 2022; 2022:5188202.
PMID: 36035282
PMC: 9402348.
DOI: 10.1155/2022/5188202.
The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs).
Mohamed A, Asa S, McCormick T, Al-Shakhshir H, Dasari A, Mauricio R
Curr Issues Mol Biol. 2022; 44(5):2015-2028.
PMID: 35678665
PMC: 9164086.
DOI: 10.3390/cimb44050136.
Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study.
Massironi S, Facciotti F, Cavalcoli F, Amoroso C, Rausa E, Centonze G
Cells. 2022; 11(4).
PMID: 35203339
PMC: 8870382.
DOI: 10.3390/cells11040692.
Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers.
Havasi A, Sur D, Cainap S, Lungulescu C, Gavrilas L, Cainap C
Int J Mol Sci. 2022; 23(3).
PMID: 35163032
PMC: 8834851.
DOI: 10.3390/ijms23031109.